Epigenetic patterns in the progression of esophageal adenocarcinoma

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3410-3418

  Eads, Cindy A ^a   Lord, Reginald V ^a   Wickramasinghe, Kumari ^b   Long, Tiffany I ^a   Kurumboor, Soudamini K ^a   Bernstein, Leslie ^a   Peters, Jeffrey H ^a   DeMeester, Steven R ^a   DeMeester, Tom R ^a   Skinner, Kristin A ^a   Laird, Peter W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS;

EID: 0035870280     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cancer epigenetics comes of age
2. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
3. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors
4. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
5. Altered expression of retinoblastoma (RB) protein in acute myelogenous leukemia does not result from methylation of the Rb promotor
6. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia
7. From genomics to epigenomics: A loftier view of life
8. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
9. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
10. Evolution of neoplastic cell lineages in Barrett oesophagus
11. Barrett's esophagus: Metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma
12. INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
13. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
14. Fields of aberrant CpG Island hypermethylation in Barrett's esophagus and associated adenocarcinoma
15. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
16. CpG island methylator phenotype in colorectal cancer
17. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
18. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
19. MethyLight: A high-throughput assay to measure DNA methylation
20. Simplified mammalian DNA isolation procedure
21. Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction
22. A modified and improved method for bisulphite based cytosine methylation analysis
23. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
24. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis
25. INK4a methylation and p53 mutational status
26. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
27. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
28. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing
29. Cyclooxygenase-2 expression in human esophageal carcinoma
30. Hypermethylation of multiple genes in pancreatic adenocarcinoma
31. Thymidine kinase activities in familial adenomatous polyposis, adenomatous polyps, and carcinoma of the colon
32. Loss of heterozygosity of methylenetetrahydrofolate reductase in colon carcinomas
33. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53
34. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas
35. Methylation and silencing of the thrombospondin-1 promoter in human cancer
36. Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer
37. Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
38. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
39. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers
40. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
41. A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells
42. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
43. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal
44. A methylated CpG island 3′ in the apolipoprotein-E gene does not repress its transcription
45. The methylation paradox
46. Progressive increases in de novo methylation of CpG islands in bladder cancer
47. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma
48. Oligonucleotides with fluorescent dyes at opposite end provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization